Literature DB >> 19291970

Computer-aided mass detection in mammography: false positive reduction via gray-scale invariant ranklet texture features.

Matteo Masotti1, Nico Lanconelli, Renato Campanini.   

Abstract

In this work, gray-scale invariant ranklet texture features are proposed for false positive reduction (FPR) in computer-aided detection (CAD) of breast masses. Two main considerations are at the basis of this proposal. First, false positive (FP) marks surviving our previous CAD system seem to be characterized by specific texture properties that can be used to discriminate them from masses. Second, our previous CAD system achieves invariance to linear/nonlinear monotonic gray-scale transformations by encoding regions of interest into ranklet images through the ranklet transform, an image transformation similar to the wavelet transform, yet dealing with pixels' ranks rather than with their gray-scale values. Therefore, the new FPR approach proposed herein defines a set of texture features which are calculated directly from the ranklet images corresponding to the regions of interest surviving our previous CAD system, hence, ranklet texture features; then, a support vector machine (SVM) classifier is used for discrimination. As a result of this approach, texture-based information is used to discriminate FP marks surviving our previous CAD system; at the same time, invariance to linear/nonlinear monotonic gray-scale transformations of the new CAD system is guaranteed, as ranklet texture features are calculated from ranklet images that have this property themselves by construction. To emphasize the gray-scale invariance of both the previous and new CAD systems, training and testing are carried out without any in-between parameters' adjustment on mammograms having different gray-scale dynamics; in particular, training is carried out on analog digitized mammograms taken from a publicly available digital database, whereas testing is performed on full-field digital mammograms taken from an in-house database. Free-response receiver operating characteristic (FROC) curve analysis of the two CAD systems demonstrates that the new approach achieves a higher reduction of FP marks when compared to the previous one. Specifically, at 60%, 65%, and 70% per-mammogram sensitivity, the new CAD system achieves 0.50, 0.68, and 0.92 FP marks per mammogram, whereas at 70%, 75%, and 80% per-case sensitivity it achieves 0.37, 0.48, and 0.71 FP marks per mammogram, respectively. Conversely, at the same sensitivities, the previous CAD system reached 0.71, 0.87, and 1.15 FP marks per mammogram, and 0.57, 0.73, and 0.92 FPs per mammogram. Also, statistical significance of the difference between the two per-mammogram and per-case FROC curves is demonstrated by the p-value < 0.001 returned by jackknife FROC analysis performed on the two CAD systems.

Mesh:

Year:  2009        PMID: 19291970     DOI: 10.1118/1.3049588

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  4 in total

1.  An interpretable classifier for high-resolution breast cancer screening images utilizing weakly supervised localization.

Authors:  Yiqiu Shen; Nan Wu; Jason Phang; Jungkyu Park; Kangning Liu; Sudarshini Tyagi; Laura Heacock; S Gene Kim; Linda Moy; Kyunghyun Cho; Krzysztof J Geras
Journal:  Med Image Anal       Date:  2020-12-16       Impact factor: 8.545

2.  Marker-controlled watershed for lesion segmentation in mammograms.

Authors:  Shengzhou Xu; Hong Liu; Enmin Song
Journal:  J Digit Imaging       Date:  2011-10       Impact factor: 4.056

Review 3.  Artificial Intelligence for Mammography and Digital Breast Tomosynthesis: Current Concepts and Future Perspectives.

Authors:  Krzysztof J Geras; Ritse M Mann; Linda Moy
Journal:  Radiology       Date:  2019-09-24       Impact factor: 11.105

Review 4.  [Applications of Artificial Intelligence in Mammography from a Development and Validation Perspective].

Authors:  Ki Hwan Kim; Sang Hyup Lee
Journal:  Taehan Yongsang Uihakhoe Chi       Date:  2021-01-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.